Blood-borne RT-PCR assay for prostasin-specific transcripts to identify circulating prostate cells in cancer patients

European Urology

Volumn 39, Issue 1, 2001, Pages 65-71

  Laribi, Abder ^a   Berteau, Pierre ^a   Gala, Jean Luc ^b   Eschwège, Pascal ^c   Benoit, Gerard ^c   Tombal, Bertrand ^d   Schmitt, François ^a   Loric, Sylvain ^a,b,e  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b INSTITUT PASTEUR   (France)

^c BICÊTRE HOSPITAL   (France)

^d CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^e HÔPITAL SAINT ANTOINE   (France)

Author keywords

Blood detection; Prostasin; Prostate cancer; Reverse transcription polymerase chain reaction

Indexed keywords

PROSTASIN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CELL ISOLATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SERINE ENDOPEPTIDASES;

EID: 0035136343     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000052414     Document Type: Article

References (40)

1. Early prostate-specific antigen relapse after radical retropubic prostatectomy: Prediction on the basis of preoperative and postoperative tumor characteristics
2. Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen
3. Review of staging modalities in clinically localized prostate cancer
4. Detection of bcr-abl transcript in chronic myelogenous leukemia patients by reverse-transcription-polymerase chain reaction and capillary electrophoresis
5. Multiplex PCR: A rapid screening method for detection of gene rearrangements in childhood acute lymphoblastic leukemia
6. Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21
7. Induction of immunity to prostate cancer antigens: Results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer
8. Genetic pattern of prostate cancer progression
9. Utilization of polymerase chain reaction technology in the detection of solid tumors
10. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer
11. Value of the preoperative detection of prostate-specific-antigen-positive circulating cells by nested RT-PCR in patients submitted to radical prostatectomy
12. Prostate-specific membrane antigen
13. Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma by using nested reverse transcription polymerase chain reaction assay based on prostate-specific membrane antigen
14. Frequency of expression of prostate-specific antigen mRNA in lung tumors
15. Detection of prostate-specific antigen mRNA and protein in breast tumors
16. Molecular expression of PSMA mRNA and protein in primary renal tumors
17. Circulating urothelial PSMA expressing cells in invasive bladder cancer
18. The expression of prostate-specific membrane antigen in peripheral blood leukocytes
19. Detection of prostate-specific antigen or prostate-specific membrane antigen-positive circulating cells in prostatic cancer patients: Clinical implications
20. Sensitivity or specificity of reverse transcriptase-polymerase chain reaction assays: The real challenge for molecular staging of prostatic carcinomas
21. Melanoma-associated antigens as messenger RNA detection markers for melanoma
22. Localization of a new prostate-specific antigen-related serine protease gene, KLK4, is evidence for an expanded human kallikrein gene family cluster on chromosome 19q13.3-13.4
23. Testisin, a new human serine proteinase expressed by premeiotic testicular germ cells and lost in testicular germ cell tumors
24. Prostase/KLK-L1 is a new member of the human kallikrein gene family, is expressed in prostate and breast tissues, and is hormonally regulated
25. Molecular cloning and characterization of prostase, and androgen-regulated serine protease with prostate-restricted expression
26. Prostasin is a novel human serine proteinase from seminal fluid: Purification, tissue distribution, and localization in prostate gland
27. Molecular cloning, tissue-specific expression, and cellular localization of human prostasin mRNA
28. Structure and chromosomal localization of the human prostasin (PRSS8) gene
29. The role of the reverse-transcriptase polymerase chain reaction assay for prostate-specific antigen in the selection of patients for radical prostatectomy
30. Sensitive detection of prostatic hematogenous tumor cell dissemination using prostate specific antigen and prostate specific membrane-derived primers in the polymerase chain reaction
31. Disease progression following radical prostatectomy in men with Gleason score 7 tumor
32. Natural history of progression after PSA elevation following radical prostatectomy
33. Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR
34. Monitoring of BCR-ABL expression using real-time RT-PCR in CML after bone marrow or peripheral blood stem cell transplantation
35. New prognostic factors in melanoma: mRNA tumour markers
36. Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients?
37. Molecular staging of prostate cancer: Dream or reality?
38. Diagnosis of micrometastases by the amplification of tissue-specific genes
39. Blood-based reverse transcriptase polymerase chain reaction assays for prostatic specific antigen: Long-term follow-up confirms the potential utility of this assay in identifying patients more likely to have biochemical recurrence (rising PSA) following radical prostatectomy
40. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer